Home     Profile     Vaginitis     WH-1 Capsule     Safety & Efficacy     Clinical Trials     Business Opportunity     Contact
WH-1 A Breakthrough in the Treatment of Vaginitis
(White discharge in women)
WH-1 is an Ayurvedic Herbal Formula developed by
Dr. V.R. Bapat, Bangalore, India. For his profile click here
He has experience of treating with this formulation over
a period of 35 years in his clinical practice.

Advantages WH-1 Treatment

Useful in all the types of vaginitis. (BV, VC, and TM)
No recurrence
Useful in Mixed infections as well
Saves cost of consultation fees of Gynecologist
Saves cost of laboratory investigations
Avoids inconvenience of physical examination experienced by woman
Treatment could be done by primary care physician or OTC
Especially useful in third world countries where lab facilities are not available
Cost effective
   
 

WH-1 Capsule – a simple alternative Option

 
   
 

WH-1 is an ayurvedic herbal formula developed by Dr. V.R. Bapat, Bangalore . India . For his profile click here . He has experience of treating with this formulation over a period of 35 years in his clinical practice.

Safety and Efficacy

Safety :
Acute oral LD50 toxicity study of test drug WH-1 conducted on rats showed no treatment related toxic signs and symptoms. The study was conducted as per OECD guidelines. The raw materials and finished product have been tested for heavy metals and microbial contents. Another study to prove the safety of the drug where Kidney Function Test and Liver Function Test are conducted before treatment and after treatment with test drug is under way. In the clinical trails there was no adverse action on any patient.

Efficacy : A clinical trial on 36 patients conducted by Department of Pharmacy Practice, Al-Ameen college of Pharmacy Bangalore found that 83% of patients of vaginitis were cured with the test drug. ( Click here for Research paper ) The duration of complaint varied from 4 days to 8 years. Most of them had received some modern treatment without any relief before they were recruited for the trial. 69% were cured with the very first course of treatment and 14% after another course of treatment. The treatment course is only 10 days. Dosage is one capsule three times a day. The sexual partner is also treated concurrently.

   
 

Outcome of Clinical Trial

 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © reserved for Dr. V.R. Bapat